Global inequality in sub-fertility treatment needs safer, cost effective, evidence-based and economically viable choices for patients and stakeholders

The global increase in subfertility diagnosis and treatments and the rise of private equity investors concentrating on high profits based on in vitro fertilisation (IVF) treatments raise profound societal and economic questions for stakeholders and patients. The question remains as to whose benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahadur, Gulam, Homburg, Roy, Muneer, Asif, Racich, Paul, Jayaprakasan, Kanna, Acharya, Santanu, Jauniaux, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brazilian Society of Assisted Reproduction 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769187/
https://www.ncbi.nlm.nih.gov/pubmed/35040304
http://dx.doi.org/10.5935/1518-0557.20210111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769187/
https://www.ncbi.nlm.nih.gov/pubmed/35040304
http://dx.doi.org/10.5935/1518-0557.20210111

Ejemplares similares